People · Operator
Named in public records as an officer, director or promoter · active 2015–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $60.5M | $696.2M | 2015 |
David J. McGirr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David J. McGirr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| NEIL EXTER | 1 | 5 |
| Keith Gottesdiener | 1 | 4 |
| Jonathan T. Silverstein | 1 | 3 |
| Edward T. Mathers | 1 | 3 |
| Todd T. Foley | 1 | 2 |
| David P. Meeker, M.D. | 1 | 2 |
| Jean Christophe | 1 | 1 |
| Christophe Jean | 1 | 1 |
| Bart T. Henderson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.